background
nucleic
acid
amplif
techniqu
improv
diagnost
possibl
respiratori
tract
infect
although
clinic
applic
yet
fulli
defin
evalu
multiplex
realtim
pcr
method
detect
respiratori
virus
bacteria
mycoplasma
chlamydophila
clinic
set
object
aim
present
studi
evalu
diagnost
perform
clinic
use
novel
multiplex
pcr
method
adult
communityacquir
respiratori
viral
infect
impact
durat
symptom
detect
rate
studi
design
nasopharyng
swab
sampl
prospect
collect
adult
outpati
respiratori
infect
asymptomat
control
result
infecti
agent
identifi
sampl
patient
asymptomat
control
detect
rate
significantli
higher
sampl
patient
durat
symptom
day
less
sampl
patient
durat
symptom
day
p
human
corona
virus
influenza
viru
b
correl
amount
viru
patient
sampl
measur
ct
valu
durat
symptom
conclus
durat
symptom
significantli
affect
detect
rate
respiratori
pathogen
multiplex
realtim
pcr
nasopharyng
swab
sampl
adult
patient
respiratori
infect
find
taken
account
use
test
clinic
practis
realtim
polymeras
chain
reaction
pcr
techniqu
gain
increas
accept
diagnosi
viral
respiratori
tract
infect
rti
high
sensit
short
analysi
time
along
abil
detect
sever
pathogen
singl
sampl
advantag
compar
serolog
viral
cultur
antigen
detect
pcr
assay
may
enhanc
identif
viral
respiratori
pathogen
least
compar
tradit
diagnost
method
partli
detect
virus
convent
method
exist
human
rhinoviru
hrv
human
coronaviru
hcov
human
metapneumoviru
hmpv
kay
et
al
found
respiratori
viru
caus
agent
adult
patient
admit
hospit
acut
rti
patient
sever
pneumonia
requir
intens
care
treatment
neg
bacteri
cultur
bronchoalveolar
lavag
bal
sampl
legoff
et
al
report
detect
respiratori
viru
much
case
virus
believ
caus
mild
upper
respiratori
tract
infect
urti
exampl
hrv
hcov
detect
lower
respiratori
tract
patient
sever
diseas
hand
known
asymptomat
shed
occur
follow
clinic
recoveri
subclin
infect
result
molecular
method
high
sensit
must
assess
caution
regard
clinic
relev
find
detect
viral
agent
respiratori
tract
sampl
use
multiplex
realtim
pcr
quick
sensit
like
replac
tradit
mean
diagnos
rti
diagnost
perform
method
adult
immunocompet
individu
optim
time
point
specimen
collect
howev
poorli
defin
aim
present
studi
evalu
diagnost
perform
clinic
use
novel
multiplex
pcr
method
adult
communityacquir
respiratori
viral
infect
impact
durat
symptom
detect
rate
conduct
prospect
studi
western
sweden
two
consecut
winter
season
octob
april
adult
patient
year
old
symptom
acut
rti
durat
less
week
includ
studi
treat
physician
acut
rti
defin
least
two
follow
symptom
coryza
congest
sneez
soar
throat
odynophagia
cough
chest
pain
short
breath
fever
physician
found
explan
patient
suspect
confirm
bacteri
infect
exclud
patient
ask
return
followup
visit
day
day
initi
visit
sign
symptom
record
webbas
form
protocol
use
initi
followup
visit
control
group
healthi
adult
without
histori
fever
symptom
rti
preced
day
also
includ
control
subject
contact
telephon
interview
day
test
individu
develop
symptom
rti
exclud
avoid
detect
viru
might
shed
high
level
prior
onset
symptom
nasopharyng
throat
swab
specimen
collect
patient
control
subject
swab
jointli
place
steril
contain
ml
sodiumchlorid
solut
sent
virolog
laboratori
day
laboratori
specimen
either
analys
directli
frozen
c
later
analysi
research
ethic
committe
gothenburg
univers
gothenburg
sweden
approv
studi
patient
gave
inform
consent
focus
analysi
virus
found
pcr
assay
although
two
bacteria
also
includ
panel
util
realtim
pcr
procedur
base
autom
specimen
extract
multiplex
amplif
primer
hydrolysi
probe
obtain
literatur
develop
laboratori
nucleic
acid
l
specimen
extract
elut
volum
l
magnapur
lc
robot
roch
molecular
system
mannheim
germani
use
total
nucleic
acid
protocol
amplifi
abi
realtim
pcr
system
appli
biosystem
foster
citi
ca
amplif
carri
l
reaction
volum
revers
transcript
step
cycl
twostep
pcr
perform
sampl
amplifi
parallel
reaction
contain
primer
probe
specif
target
previous
describ
ct
valu
cycl
threshold
patient
sampl
posit
realtim
pcr
record
semiquantit
estim
amount
dnarna
specimen
chisquar
test
use
compar
proport
spearman
rank
correl
coeffici
analys
correl
pvalu
consid
signific
sampl
posit
one
microbi
agent
n
one
patient
exclud
prospect
due
bacteri
tonsil
one
patient
exclud
retrospect
due
pneumococc
sepsi
two
hundr
nineteen
patient
symptom
rti
asymptomat
control
includ
studi
ten
patient
exclud
tabl
leav
final
analysi
infecti
agent
identifi
patient
control
demograph
characterist
agent
detect
present
tabl
case
enterovirus
chlamydia
pneumonia
identifi
posit
outcom
n
one
agent
identifi
data
shown
durat
symptom
rang
day
major
patient
includ
within
first
day
diseas
detect
rate
significantli
higher
sampl
patient
durat
symptom
day
less
sampl
patient
durat
symptom
day
p
fig
hcov
ifa
ifb
correl
ct
valu
durat
symptom
n
rs
p
n
rs
p
n
rs
p
hrv
correl
found
fig
two
patient
influenza
omit
result
incongru
patient
histori
data
shown
total
n
patient
return
followup
visit
day
initi
visit
nasopharynxthroat
swab
sampl
collect
patient
posit
sampl
initi
visit
patient
show
followup
test
pathogen
detect
patient
see
tabl
eight
sampl
posit
viru
initi
followup
visit
posit
hrv
new
microbi
agent
found
five
subject
still
respiratori
tract
symptom
followup
patient
still
posit
agent
followup
higher
ctvalu
correspond
lower
tabl
followup
day
initi
visit
test
result
analysi
realtim
pcr
nasopharyngealthroat
swab
specimen
amount
viral
rna
specimen
day
later
except
one
patient
hrv
occas
data
shown
shown
diagnost
yield
increas
significantli
multiplex
pcr
assay
respiratori
virus
use
within
initi
day
symptom
immunocompet
adult
rti
concord
report
singleplex
pcr
assay
influenza
detect
rate
correl
durat
symptom
detect
infecti
agent
patient
previous
detect
rate
rang
describ
except
high
rate
among
young
children
infant
asymptomat
children
higher
frequenc
posit
result
report
particular
detect
hrv
ev
may
repres
previou
infect
date
back
week
due
prolong
shed
viru
lack
preexist
immun
greater
viral
exposur
well
immatur
immun
system
may
caus
higher
level
viral
replic
prolong
viral
shed
children
templeton
et
al
report
detect
rate
hrv
hcov
adv
hmpv
includ
panel
studi
perform
retrospect
clinic
sampl
select
short
durat
symptom
studi
includ
children
tend
seek
medic
care
earli
may
shed
viru
longer
time
period
thu
prospect
approach
adult
popul
may
explain
rel
low
detect
rate
found
sampl
studi
period
includ
influenza
season
detect
influenza
b
viru
rel
high
proport
patient
compar
studi
adult
detect
pathogen
control
subject
hrv
although
studi
includ
control
creer
et
al
found
respiratori
viru
control
report
sign
respiratori
tract
infect
month
sampl
predominantli
hrv
asymptomat
shed
hrv
rsv
piv
also
report
immunocompromis
patient
result
suggest
viral
shed
exceed
day
rare
immunocompet
adult
rate
asymptomat
carriag
viru
might
affect
epidemiolog
factor
vari
time
control
sampl
howev
collect
throughout
entir
studi
period
sever
virus
analys
studi
amount
viral
dnarna
decreas
durat
symptom
suggest
gradual
reduct
viral
shed
epitheli
surfac
time
concord
gradual
reduct
rsv
level
nasopharyng
aspir
describ
gerna
et
al
campanini
et
al
dual
viral
infect
previous
describ
approxim
infect
patient
higher
frequenc
among
young
children
accord
previou
studi
found
two
virus
sampl
clinic
impact
multipl
infect
remain
determin
one
studi
children
rsv
infect
higher
fever
longer
hospit
stay
frequent
use
antibiot
associ
multipl
infect
semiquantif
viral
dna
measur
ct
valu
may
use
determin
clinic
relev
posit
test
particularli
multipl
infect
found
correl
ct
valu
durat
symptom
hcov
ifa
ifb
hrv
high
genet
variabl
hrv
increas
probabl
probetarget
mismatch
may
explain
virus
influenza
b
viru
less
genet
variabl
viral
detect
stabl
lack
associ
durat
ill
ct
valu
hrv
infect
may
also
reflect
variat
viral
shed
differ
preexist
immun
individu
well
limit
sampl
size
interestingli
major
patient
posit
agent
followup
visit
day
day
hrv
whether
translat
longer
period
infect
remain
determin
howev
semiquantit
estim
viral
load
ct
valu
must
interpret
caution
sinc
rel
viral
load
compar
standard
amount
viru
clinic
relev
outcom
multiplex
pcr
test
respiratori
virus
yet
fulli
determin
agent
influenza
b
viru
posit
test
may
provid
basi
antivir
treatment
suggest
rapid
etiolog
diagnosi
viral
rti
could
reduc
unnecessari
prescript
antibiot
remain
shown
conclud
durat
symptom
affect
detect
rate
realtim
multiplex
pcr
adult
patient
rti
durat
symptom
taken
account
use
test
clinic
practis
virus
rel
low
genet
variabl
semiquantif
might
valu
interpret
result
one
respiratori
viru
found
none
declar
